Corona T, Cervantes-Arriaga A, Velásquez-Pérez L, Rodríguez-Violante M

Language: English
References: 8
Page: 176-180
PDF size: 62.06 Kb.

ABSTRACT

Background: Outpatient clinics for movement disorders provide specialized diagnosis and treatment services for the specific needs of this patient population. Objective: Describe the impact of implementing a Movement Disorder Clinic on the trends of consultations per year and hospitalizations of subjects with Parkinson’s disease at a tertiary referral center. Methods: A retrospective study was carried out. We collected data from the Clinical File Archive and the Epidemiology Department at the National Institute of Neurology and Neurosurgery in Mexico. Data from January 1, 1999 through December 31, 2015 were included for analysis. Results: The number of total consultations had an increase of 632.1% between 1999 and 2015. Follow-up visits represented up to 95% of the consultations. Peaks found correlated with the inclusion of new specialists in the clinic. Regarding hospitalization, the number of patients discharged with a diagnosis of Parkinson’s disease increased from a median of 17 (range 9-35) to 46 patients (range 31-53) per year. Conclusions: The implementation of a multidisciplinary Movement Disorders Outpatient Clinic in a tertiary referral center had a direct impact on the total number of consultations per year, mainly follow-up visits. The latter may reflect in an improvement in the quality of care.

REFERENCES

1. Siemers E, Reddy V. Profile of patients enrolled in a new movement disorder clinic. Mov Disord. 1991;6:336-41.

2. Poon LH, Lee AJ, Chiao TB, Kang GA, Heath S, Glass GA. Pharmacist’s role in a Parkinson’s disease and movement disorder clinic. Am J Health Syst Pharm. 2012;69:518-20.

3. Yssel J, Casey E, O’Rourke K, Magennis B, Lynch T. The role of a movement disorders clinic. Ir Med. 2012;105:57-9.

4. Rochow SB, Blackwell AD, Brown VJ. Quality of life in Parkinson’s disease: movement disorders clinic vs general medical clinic--a comparative study. Scott Med J. 2005;50:18-20.

5. Müller T, Voss B, Hellwig K, Josef Sten F, Schulte T, Przuntek H. Treatment benefit and daily drug costs associated with treating Parkinson’s disease in a Parkinson’s disease clinic. CNS Drugs. 2004;18:105-11.

6. Meeuwsen EJ, Melis RJ, Van Der Aa GC, et al. Effectiveness of dementia follow-up care by memory clinics or general practitioners: a randomised controlled trial. BMJ. 2012;344:e3086.

7. Habibi M, Kuttab HM. Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems. Am J Health Syst Pharm. 2016;73:811-19.

8. Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord. 2010;25:534-41.